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Nitric oxide (•NO) production in response to stimulation of the
NMDA glutamate receptor is implicated not only in the synaptic
plasticity in hippocampus but may also participate in excitotoxic
cell death. Using •NO-selective microssensors inserted into the
diffusional field of •NO in acute hippocampal slices, we describe
the •NO concentration dynamics evoked by NMDA receptor acti-
vation and report profound differences along the trisynaptic loop
of the hippocampus. We measured the oxygen gradient across the
slice thickness and conclude that •NO measurements were per-
formed at cell layers experiencing physiological oxygen tensions.
Recordings performed at increasing distances from the point of
NMDA receptor stimulation resulted in a progressive decrease of
•NO signals, reaching undetectable levels for distances >400 m,
supporting the notion of a wide diffusional spread of endoge-
nously generated •NO in the hippocampus. Neither a picoinjection
nor a continuous perfusion of NMDA resulted in high steady-state
•NO levels; rather all signals were transient, suggesting that cells
are able to efficiently respond to high •NO concentrations (typically
200–400 nM) bringing it to very low nM levels; the claimed high
micromolar •NO range achieved by excessive stimulation of NMDA
receptor may have to be reevaluated. The distinct responses to
NMDA receptor stimulation along the trysynaptic loop suggest a
differential •NO activity andor regulation among the hippocampal
subregions. These findings may be relevant for the understanding
of the role of •NO in physiologic mechanisms in the hippocampus
and the differential sensitivity of the hippocampal subregions to
NMDA receptor-dependent neurodegeneration.
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A neural role of nitric oxide (•NO) as an intercellular signalingmolecule in the nervous system was first suggested by Garth-
waite and Boulton (1), who related the activation of glutamate
NMDA receptor and •NO synthesis in brain slices. This notion has
been confirmed by subsequent studies (for review see ref. 2).
Conversely to conventional messenger molecules in the brain,
because of its low molecular weight, hydrophobic nature, and very
high diffusion constant, •NO diffuses isotropically from its site of
synthesis regardless of overruling cellular or membrane structures
(3, 4). Thus, the current understanding of •NO bioactivity in the
brain implies the formation of a ‘‘sphere of influence’’ of •NO
affecting a volume of tissue containing many neurons irrespective
of functional connections through synapses; i.e., •NO operates as a
diffusible intercellular messenger. A critical tenet of •NO bioactiv-
ity establishes that its actions at any location are determined by the
local •NO concentration (5). Yet, the evaluation of •NO in terms
of concentration dynamics has been limited because of the diffi-
culties in measuring •NO with spatiotemporal resolution and
appropriate sensitivity and selectivity. Although it has been shown
that •NO produced postsynaptically exerts actions at the presyn-
aptic level (6–9), the quantification of the diffusional spread of
endogenously generated •NO in the brain lacks experimental
evidence. Theoretical modeling predicted that •NO produced from
a single physiologic source for 1–10 s diffuses within a 200-m-
diameter sphere (4).
The hippocampus is a structure of the brainmedial temporal lobe
implicated in declarative memory formation (10) affected during
aging and Alzheimer’s disease (11). At glutamatergic synapses in
hippocampus (12), the link between NMDA receptor activation
and the production of •NO by neuronal NO synthase (nNOS) is
Ca2 entry through the activated receptor channel, leading to the
formation of the Ca2calmodulin complex, which in turn is
capable of activating intracellular nNOS (1).
The measurement of •NO dynamics during functionally induced
changes in the hippocampus by activation of the NMDA receptor
has generated much interest inasmuch as the activation of this
receptor is essential to signaling pathways that underlie neuronal
plasticity, but also triggers neurodegeneration that occurs in senes-
cence and disease, suggesting a role for •NO in these processes (13).
For instance, in the CA1 and dentate gyrus (DG) subregions of the
hippocampus, long-term potentiation (LTP) is triggered by the
activation of the NMDA receptor as a result of heavy stimulation
of the presynaptic terminal (14). In this context, •NO has been
suggested to be the diffusible retrograde messenger required for
LTP (15, 16).
Excessive activation of the NMDA receptor mediates neurode-
generation in neurological disorders, inducing Alzheimer’s disease,
Parkinson’s disease, multiple sclerosis, and AIDS dementia (13,
17). •NO has been implicated in such excitotoxic phenomenon in a
variety of cellular model systems (13, 18).
All of this information leads to the notion of •NO as a crucial
mediator of pathophysiological pathways in the hippocampus. Yet,
knowledge regarding the concentration dynamics of endogenously
produced •NO is scarce and, clearly, this knowledge is imperative
in understanding its role in signaling pathways. In this study, we use
microssensors developed to monitor the dynamics of •NO produc-
tion and decay in the different subregions of acute rat hippocampal
slices upon stimulation of the NMDA receptor. First, we deter-
mined the spread of endogenously generated •NO and, then,
inserting the sensors within the diffusional field of •NO, we studied
its concentration dynamics and provided evidence for a heteroge-
neous distribution and transient nature of •NO signals as a function
of the hippocampal subregion.
Materials and Methods
Chemicals and Solutions. NMDA, D-(-)-2-amino-5-phosphonopen-
tanoic acid (D-AP5), and NG-nitro-L-arginine (L-NNA) were ob-
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tained from Tocris Cookson (Avonmouth, U.K.). Ascorbate (AA),
dopamine, and o-phenylenediamine were from Fluka. 5-Hydroxy-
tryptamine, glutathione, diethylenetriaminepentacetic acid, and
diethylenetriaminenitric oxide adduct were from Sigma. Nafion
was from Aldrich, and nitrite was from Merck. All other reagents
were reagent grade.
Buffer used for microsensor testing and calibrations was PBS
with the following composition: 140 mM NaCl, 2.7 mM KCl, 8.1
mM NaHPO4, 1.8 mM KH2PO4, and 0.1 mM diethylenetriamine-
pentacetic acid, pH 7.4.
Media for hippocampal slice experiments were artificial ce-
rebrospinal f luid (aCSF) composed of 124 mMNaCl, 2 mMKCl,
25 mM NaHCO3, 1.25 mM KH2PO4, 1.5 mM CaCl2, and 10 mM
D-glucose. For dissection and recovery modified aCSF was used
to increase viability. Composition of this aCSF was 124 mM
NaCl, 2 mM KCl, 25 mM NaHCO3, 1.25 mM KH2PO4, 0.5 mM
CaCl2, 10 mM MgSO4, 0.2 mM AA, 1 mM glutathione, and 10
mM D-glucose. In both cases, aCSF was continuously bubbled
with humidified carbox (95%O25%CO2) for pH buffering (pH
7.4) and oxygenation.
Electrochemical Instrumentation. Fast cyclic voltammetry was car-
ried out on an EI-400 potentiostat (Ensman Instruments, Bloom-
ington, IN), and signals were monitored on a digital storage
oscilloscope (Tektronix TDS 220).
Amperometric currents from microsensor modification and cal-
ibration and oxygen measurements in tissue were recorded on a
PGSAT 12 potentiostat (EcoChimie, Utrecht, The Netherlands)
with low current module, controlled by GPES software, version 4.9.
Amperometric currents recordings in slices were performed on the
inNO model T electrochemical detection system (Innovative In-
struments, Tampa, FL).
In hippocampal recordings of both •NO and O2, a two-electrode
circuit was used, with aAgAgCl pellet as a reference electrode and
the microsensor as a working electrode. For other experiments, a
three-electrode cell with a Pt-wire auxiliary electrode, a AgAgCl
(3M) reference electrode, and the microsensor as a working elec-
trode was used.
The working electrode was held at a constant potential of
either0.9 or0.8 V for •NO orO2measurements, respectively.
•NO Microsensor Construction and Surface Modification. Microsen-
sors were fabricated as described (19–21). Briefly, single carbon
fibers (8 m i.d.; Courtaulds, London) were inserted into borosili-
cate glass capillaries (1.16 mm i.d.  2.0 mm o.d.; Harvard
Apparatus), cleaned with acetone, and pulled on a vertical puller
(Harvard Apparatus).The protruding carbon fibers were cut to tip
length of100m. The electrical contact between the carbon fiber
and the copper wire was provided by conductive silver paint (RS,
Northants, U.K.).
Microsensors were first coated with Nafion by dipping the fiber
into a Nafion solution at room temperature for 30 s and drying for
10 min at 170°C in an oven. Microsensors were then modified by
electropolimerization of o-phenylenediamine (o-PD) as described
(22).A 5-mM o-PD solution in PBS supplementedwith 0.1mMAA
was made fresh each day and used immediately. Electropolimer-
ization on the carbon surface was preformed by amperometry at
constant potential of 0.9 V vs. AgAgCl for 15 min.
Microsensor Testing Procedures. Each microsensor was tested for
general recording characteristics in PBS by using fast cyclic volta-
mmetry at a scan rate of 200 Vs between 0.4 and 1.6 V. This
potential range provides an electrical pretreatment of the carbon
fiber that improves sensitivity. A stable background current and
sharp transients at reversal potentials indicated suitable recording
properties of the microsensor.
Themicrosensors for •NOwere calibrated by a single stream flow
injection analysis system by using a homemade flow cell with PBS
as a carrier solution at a flow rate of 2.0 mlmin. Transient
oxidation currents were measured in response to 100 l of dieth-
ylenetriamineNO adduct solution in deaerated PBS injected re-
peatedly with a four-valve port.
The microelectrodes for O2 measurement were calibrated in a
2-ml cell with PBS as a support electrolyte. The reduction current
was measured for three distinct O2 tensions (0, 156, and 700 torr)
achieved by bubbling the PBS with argon, allowing it to achieve
atmospheric PO2 and bubbling it with Carbox, respectively.
Rat Hippocampal Slices.MaleWistar rats (100–150 g) were killed by
cervical displacement according to approved guidelines. The brain
was rapidly removed and placed in ice-cold modified aCSF. The
hippocampi were dissected and placed on the stage of a McIlwain
tissue chopper (Campden Instruments, London), and 400-m-thick
sections were obtained. The slices were separated and transferred
to a preincubation chamber (BSC-PC, Harvard Apparatus) con-
taining modified aCSF at room temperature, continuously bubbled
with Carbox. Slices were recovered under these conditions for at
least 1 h before recordings.
Recording •NO Concentration Dynamics. Individual sliceswere placed
in a recording chamber (BSC-BU with BSC-ZT top, Harvard
Apparatus) and perfused with normal aCSF at 32°C (temperature
controller model TC-202A, Harvard Apparatus) continuously bub-
bled with humidified Carbox at a flow rate of 2 mlmin. A
microsensorwas placed in the desired subregionof the hippocampal
slice (for CA1 and CA3 subregions the microsensor was placed at
the level of the pyramidal cell layer and in the DG at the granular
cell layer) 100–200 m into the tissue. These sites are known to be
concentrated in nNOS (23, 24) and were easy to identify, enabling
precise reproduction of microsensor insertion.
For slice stimulation, a pressure ejection protocol was applied,
using a Picospritzer II (General Valve, Fairfield, NJ). A glass
pipette capillary with an inner tip diameter of 8 m was filled with
stimulation solution (5 mM NMDA in 0.1 M phosphate buffer
containing 154 mM NaCl, pH 7.4) and placed at the slice surface
50 m away (or as otherwise indicated) from the point of
insertion of the microsensor. A 3-s pulse was applied at a pressure
of 10 psi. In experiments where antagonists or inhibitors were used
these drugs were added to the perfusion media.
Measurement of PO2 Across Slice Thickness. The oxygen tension
(PO2) across the hippocampal slice wasmeasured as described (25).
Bare carbon fiber microelectrodes were prepared as described
above for the •NO microsensor, with no surface modification. The
exposed tip was cut at 10–20 m to increase spatial resolution in
recordings.
The microelectrode was placed at different depths (surface,
100, 200, 300, or 400 m) of the tissue with the help of a
micromanipulator.
Data Analysis. Data are expressed as the mean  SEM and were
analyzed for statistical significance defined as P  0.05 using
Student’s t test. Total charge was calculated as the time integral of
the amperometric current.
The individual •NO recordings obtained in the different subre-
gions of hippocampal slices challenged with NMDA were divided
into two phases: ascendant and descendent. The ascending phase
was fitted to a sigmoid function, which allowed theT80 for this phase
to be calculated. The descending phase was fitted to an exponential
first-order decay function and the time constant was calculated for
each recording.
All analysis was performedwith commercially available software.
Results
Determination of •NO Diffusion Field in Hippocampal Slices. Experi-
ments illustrated in Fig. 1 were aimed at determining the diffusional
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field of •NO, after activation ofmultiple NOSs viaNMDA receptor
in theCA1 subregion of the hippocampal slice. The •NO sensor was
placed at increasing distances from the site of stimulation by
ejection of NMDA, namely 0, 100, 200, 300, and 400 m. The
stimulation parameters were selected to guarantee that NMDA
diffusion in the tissue was kept100 m, which was accomplished
by decreasing the ejection time to 500 ms (the NMDA concentra-
tion and the ejection pressure were maintained at 5 mM and 10 psi,
respectively). This condition was reached by measuring the diffu-
sional field of a 5-mM solution of AA (assumed to have a diffusion
in the tissue similar to that of NMDA) in the hippocampal slice by
using a bare carbon fiber microelectrode inserted in the tissue.
As shown in Fig. 1, as one draws back from the site of NMDA
stimulation, the amplitude of the recorded •NO signal decreases
significantly, becoming undetectable 400 m. It is noteworthy
that this experimental figure is in general agreement with published
theoretical calculations for •NO diffusion in tissues (3–5, 26).
Determination of Oxygen Gradients in Hippocampal Slices. The re-
action of •NO with O2 is slow under the normoxic conditions of
tissues (27), and, although little is known about how •NO is
inactivated, the reaction with O2 in tissues is not likely to be a
significant contributing route for •NO decay. However, at variance
with the physiological environment, the reaction of •NO with O2
may acquire significance for the high oxygen tensions used in the
perfusion experimental system, thus misleading •NO dynamics by
enhancing the rate of •NO decay. Therefore, we measured the
tension of O2 across slice thickness. The results shown in Fig. 2A
indicate a steep gradient of oxygen decreasing from the surface to
the inner cell layers. At 200 m deep (Fig. 2B) the tension of O2 is
6 1 torr (n 8), which, considering that the reportedO2 tension
in the CNS of rat is 10–30 torr (28–30), indicates that at the core
of the tissue slice the measured •NO dynamics are not erroneously
affected by a nonphysiological O2 tension.
Dynamics of •NO Concentration in the Different Subregions of the Rat
Hippocampal Slices. To study the concentration dynamics of •NO in
the distinct subregions of the hippocampal slice, NMDA (5 mM
solution) was ejected at the surface of the tissue, on top of the
microssensor insertion point and for a period of 3 s, to guarantee
maximal receptor activation. Typical recordings obtained in the
stratum pyramidale of subregions CA1 and CA3 and the stratum
granulosum of the DG subregion are shown in Fig. 3A.
Values of T80 of the ascending phase and the decay constants of
the descending phase of •NO signals in the different subregions are
indicated in Table 1. Regarding the kinetics of •NO increase, no
significant difference (P 0.05)was seenwhen comparingCA1and
CA3 subregions. However, T80 was significantly (P  0.05) longer
for DG, as compared with the other subregions, reflecting a much
slower production of •NO.No significant differenceswere observed
in the decay phase (P  0.05).
The charge produced during the oxidation of •NO at the sensor
active surface (which is linearly proportional to •NOconcentration)
was calculated for the different subregions (Fig. 3B). Among all
regions, the CA1 showed the largest production of •NO upon
stimulation with NMDA. For the experimental conditions selected,
a typical peak of •NO in CA1 subregion was 300 80 nM (n 41)
but in the other subregions average •NO levels reached 50 nM.
Blocking the NMDA Receptor with D-AP5. To confirm that •NO
production was a result of the specific activation of NMDA recep-
tor, the effect of the NMDA receptor antagonist D-AP5 was
examined on NMDA-induced signals measured in the CA1 subre-
gion (because responses to NMDA receptor activation were both
more robust and reproducible in this subregion). Fig. 4 shows the
effect of D-AP5 added to the perfusion media after a typical
response was obtained for a standard stimulation. After 20 min of
perfusion with D-AP5, the slice was stimulated for a second time.
The NMDA receptor antagonist was then washed out for 20 min
before the slice was again stimulated with NMDA. As illustrated in
Fig. 4, D-AP5 substantially decreased •NO production and, after its
removal from the perfusion medium, the response increased to the
values typically obtained for a second stimulation. In the CA1
subregion, the average decay in amplitude of signal from the first
to second stimulation was 44.9 6% (n 28, data not shown) and
4.0  1.7% (n  3) in the absence and presence of D-AP5 during
the second stimulation, respectively.
Inhibition of NOS. TheNOS inhibitor L-NNAwas used to verify that
the enzyme was responsible for observed signals evoked by activa-
tion of the NMDA receptor. Fig. 5 shows a typical recording in the
CA1 subregion of the hippocampus documenting the effect of
L-NNA (a competitive inhibitor of NOS) added to the perfusion
medium after an initial response to NMDA. Treatment with 200
M L-NNA inhibited •NO production upon a second stimulation
with NMDA. After a first stimulation, the signals subsequent to the
Fig. 1. Diffusional spread of •NO produced upon NMDA receptor activation.
The •NO microssensor was inserted in the CA1 pyramidal cell layer, and the
stimulation pipette was placed at increasing distances: 0 m (a), 100 m (b),
200 m (c), 300 m (d), and 400 m (e). The stimulus consisted of a 500-ms
ejection of NMDA (5 mM).
Fig. 2. Oxygen tension (PO2) along the hippocampal slice depth. (A) Dem-
onstrated is the dramatic decrease in PO2 when the sensor was placed at the
surface of the tissue and then at increasing depths into the tissue. (B) Shown
is the PO2 gradient within the tissue. Recordings were performed in the CA1
pyramidal cell layer of the hippocampal slice.
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second stimulation are 44.9 6.0% (n 28) and 8.8 4.3% (n
3) in the absence and presence of L-NNA, respectively.
Continuous Stimulation of the NMDA Receptor. Because brief stim-
ulation in the CA1 subregion by pressure ejection resulted in a
transient increase in •NO concentration, the question arose as to
whether prolonged exposure toNMDA could lead to a steady-state
rise in the free radical concentration. Fig. 6 shows that even when
the tissue was continuously perfused with 10 M NMDA •NO
production was transient (Fig. 6A), although more robust than in
the case of brief stimulation. Also, when the competitive NMDA
receptor antagonist D-AP5was added during the decay phase of the
signal (Fig. 6B), decay rate increased, but not abruptly, indicating
that the active receptor was still functionally coupled to •NO
production.
Discussion
The activity of •NO as an intercellular signaling molecule in the
brain has been generally established with experimental models
using •NO donors, inhibitors of •NOS, and the so-called ‘‘•NO
scavengers,’’ or, alternatively, in experimental models that do not
involve the measurement of endogenously produced •NO, but use
indirect measurements that require sample processing and lack
spatiotemporal resolution (2, 31, 32).
This work provides evidence for heterogeneous •NO concentra-
tion dynamics in the hippocampal sugregions, functionally depen-
dent on the stimulation of the NMDA subtype of glutamate
receptor (Fig. 3). Considering the evanescent nature of •NO as a
diffusible messenger in the hippocampus, its measurement with an
electrochemical microsensor inserted in the •NO diffusional field,
experimentally determined in our system, provided the appropriate
spatial resolution. Further critical features of the measurements
performed include real-time analysis, sensitivity in the low nM
range, and high selectivity against interfering substances potentially
present at high concentrations such as indols, catechols, and AA
(20). The inhibition of the •NO signal by a NOS inhibitor (Fig. 5)
strongly supports the selective measurement of •NO. Instrumental
controls (see Figs. 7 and 8, which are published as supporting
information on the PNASweb site) involving amperometry at0.9
vs.0.4 V and differential pulse amperometry further contributed
to support the selectivity of measurements performed. Briefly, a
comparison between the total charge produced in the CA1 subre-
Table 1. The T80 for sigmoidal increase and time constant of the
decay calculated from NMDA-induced •NO signals in different
subregions of the rat hippocampal slice
Subregion
Parameters
T80 (s)  SEM Time constant (s)  SEM
CA1 45  8 247  16
CA3 43  9 174  74
DG 141  34 211  30
Fig. 3. NMDA-evoked •NO production in hippocampus. (A) Typical current
recordings in distinct subregions of the rat hippocampal slice. In the CA1 and CA3
subregions recordings were performed in the pyramidal cell layer, and in the DG
they were performed in the granular cell layer. (B) Average charge was measured
in each subregion upon NMDA receptor activation. Statistical analysis of the
differences were assessed by Student’s t test (*, P 0.05; **, P 0.05).
Fig. 4. Typical recording of oxidation currents in the CA1 pyramidal cell layer
of the hippocampal slice with and without D-AP5, a competitive inhibitor of
NMDA receptors.
Fig. 5. Typical recording of the effect of L-NNA (200 M), a competitive
inhibitor of NOS, in •NO signals evoked by pressure ejection of NMDA (5 mM)
for 3 s in the CA1 pyramidal cell layer. The inhibitor was added to the perfusion
media after a positive response to a first stimulation was obtained.
17486  www.pnas.orgcgidoi10.1073pnas.0503624102 Ledo et al.
gion for the two working potentials, 0.9 and 0.4 V, shows that
at 0.9 V total charge of recorded signals was 23  4 nC (n 
35) and at 0.4 V total charge was 1.1  0.6 nC (n  7).
Moreover, a differencial pulse amperometry recording in the CA1
subregion followed similar kinetics to the amperometric recordings
and 10 M of dopamine, 5-hydroxytryptamine, and AA were not
significantly detected, as would be expected because only electro-
active species oxidized between 0.7 and 0.9 V are detected.
Finally, •NO dynamics were measured in the cell layers experienc-
ing anO2 tension similar to that found in vivo (Fig. 2), thus excluding
a reaction with O2 as a major route for •NO decay.
There are a number of possible cellular sources for constitutive
NOS activity in the hippocampus, including nNOS from neurons
and interneurons, endothelial NOS from endothelial cells in blood
vessels (33–38), and constitutive NOS activity deriving from astro-
cytes (39). The use of NMDA as the test stimuli imparts specificity
to the production of •NOvia theNMDAglutamate receptor-nNOS
pathway.
Specifically, the major findings can be listed as follows: (i) the
diffusional field of •NO upon stimulation of multiple NOSs within
a radius of 100 m is400 microns in the CA1 subregion; (ii) •NO
signals are transient even under conditions of continuous stimula-
tion of the NMDA receptor; (iii) •NO is produced in all subregions
in response toNMDAreceptor stimulation; (iv) •NOconcentration
dynamics (rate and pattern of production and decay) is heteroge-
neous along the trisynaptic loop in the cell body layers of the CA1,
CA3, and DG subregions; (v) a steep gradient of O2 is operative in
the slice cell layers, being physiological at the core of the tissue; (vi)
cells efficiently bring •NO to low nM levels, preventing high steady
concentrations; and (vii) at variance with current dogma, the
NMDA receptor does not suffer a feedback blockage by •NO.
Experimental evidence and theoretical models for •NOdiffusion
in biological settings support the notion that •NO is highly diffusible
(diffusing more rapidly than it reacts) and spreads randomly in all
directions driven by a spatial concentration gradient from its local
of synthesis (3–5, 26, 40, 41). In addition to its diffusibility, the
amount and rate at which it is generated, the duration of release
froma source cell, and the type and number of targets in the vicinity
as well as the rate (and compartmentalization) of chemical reac-
tions shape the •NO concentration-time profile. The experimental
approach used in this study implies that multiple •NO sources
within a tissue volume are simultaneously activated by the localized
ejection of NMDA. Under these conditions, encompassing the
diffusion of NMDA in the tissue and a perfusion flow of 2 mlmin,
•NO diffused at least400 microns from the NMDA ejection site.
Of note, within this tissue volume, •NO signals are transient. The
transitory nature of •NOsignalswas also observed under conditions
where the slices were continuously perfused withNMDA (Fig. 6A).
However, in this case, the decay was linear and slower compared
with the ejection approach, which is characterized by an exponential
decay (e.g., Fig. 3A), and D-AP5 brings •NO to basal levels, thus
suggesting that NMDA receptor-dependent •NO synthesis is op-
erative (Fig. 6B). The perfusion system is unlikely to determine the
transitory nature of the signals as perfusion of a 400 nM solution
of •NO prepared from •NO gas induced a constant signal (data not
shown). These observations suggest that, at variance with what is
conventionally expected, maintaining a continuous and simulta-
neous activation of multiple cellular •NO sources does not result in
a monotonous rise of •NO or high steady-state concentrations,
rather the concentration of •NO rises transiently. The decay of •NO
observed under continuous perfusion is not likely to be accounted
for by a negative feedback of NOS (42, 43) or the NMDA receptor,
known to occur through S-nitrosylation of specific SH residues
(44–49), for D-AP5would have induced no inhibition of •NOdecay
kinetics. Thus, the results suggest the occurrence ofmechanisms for
the prevention of high steady-state •NO concentrations. In agree-
ment with this notion, it has been recently proposed that brain cells
possess powerful •NO inactivation mechanisms that shape •NO
signals (50, 51). At variance with the synthesis of •NO by NOS,
which is a highly regulated process (52), its decayconsumption is
thought to be anunregulated process, depending largely on the local
availability of potential targets (hemoglobin, soluble guanylate
cyclase, cytochrome oxidase, superoxide anion, thiol groups. . .).
The results shown here are consistent with the view whereby brain
cells are able to efficiently respond to a high •NO concentration
bringing it to very low nM levels.
The subregional differences in •NO signals evoked with NMDA
raise at least two important questions: what are the underlying
mechanisms and how do these differences translate into tissue
physiological activity?
Regarding the latter, it may be noted that the strength of •NO
responses in CA1 pyramidal neurons accomplishes an essential
requirement posed by the notion of •NO as a messenger in synaptic
plasticity mechanisms linked to memory and learning: NMDA-
dependent LTP (53) is seen mainly in the CA1 subregion of the
hippocampus; in CA3 a different type of potentiation is observed
(54). Moreover, in humans, a regional-specific neuron loss in CA1
region is associated with the cognitive decline in Alzheimer’s
disease (55). Thus, one might expect to see differences in •NO
concentration dynamics in CA1 relative to CA3 and DG.
The elucidation of the mechanisms that support the subregional
differences of •NO signals is an open question. It is currently
conceived that the neuronal isofoform of NOS is not confined to
small specific areas, but is distributed in a small population of
neurons throughout brain areas, including hippocampus (36). As-
suming a homogeneous distribution of nNOS andNMDAreceptor,
the heterogeneous concentration dynamics of •NO among the
subregions of hippocampus evoked by stimulation of NMDA
receptors suggests a region–specific regulation of •NO bioactivity.
However, despite species and development variations in hippocam-
pal nNOS (37), there may also be a gradient of expression of nNOS
in the subregions of the hippocampus. A recent report showed a
higher level of nNOS expression in the CA1 subregion of the rat
hippocampus, but these observations weremade in the total extract
of each region in a manner that cannot distinguish between nNOS
that is coupled to the NMDA receptor and nNOS present in other
cellular compartments (38). Also, the differences reported are not
as large as the ones shown in this study for •NO production.
It may be argued that the differential level of expression of the
NMDA receptor in the subregions of the hippocampus may ac-
count for the differential NMDA-dependent •NO signals observed.
Fig. 6. •NO production evoked by continuous perfusion of 10 M NMDA.
Recordings were performed in the CA1 pyramidal cell layer of rat brain slices.
(A) A continuous stimulation with NMDA. (B) A continuous stimulation with
addition of 25 M D-AP5 during the decay of the signal. Typical recording is
representative of several done.
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This type of glutamate receptor ismore highly expressed in theCA1
subregion (56). In agreement with this hypothesis, reports on the
production of •NO in hippocampal subregions not dependent on
NMDA receptors showed less significant differences of •NO pro-
duction as compared with those in this study. Smith et al. (57), using
nicotine as the stimulus for •NOproduction, reported that CA3 and
DG peak amplitudes were 70% of peak amplitude in CA1 area.
More recently, a bioimaging approach with diaminofluorescein
derivatives indicated that •NO is produced mainly in the CA1 area
in hippocampal slices under ischemic conditions (58).
Finally, the NMDA receptor and nNOS may be modulated at
different levels in the different subregions by mechanisms that may
range from the organization of the NMDA receptor–postsynaptic
density-95 protein–nNOS molecular complexes through protein–
protein interactions to the action of superoxide anion (O2
•). For
instance, PIN, the protein inhibitor of nNOS expressed in the
hippocampus, inhibits nNOS by binding to monomers and thus
blocking dimerization or even by dissociating already formed
dimers (59, 60).
Likewise, O2
• produced by NMDA receptor activation ap-
pears to work in conjunction with •NO during induction of LTP
in hippocampus (61). It is noteworthy that in rat brain the
localization of CuZn-SOD overlaps with that of NOS in the
pyramidal cell layers of CA1, CA3, and DG subregions of
hippocampus (62). Also, a regional vulnerability to O2
• has been
reported in organotypic hippocampal slice cultures, being CA1
pyramidal neurons selectively affected (63), a pattern of damage
similar to that observed after hypoxiaischaemia (64). Consid-
ering the very fast reaction of both superoxide dismutase (SOD)
[K  2.3  109 M1s1 (65)] and •NO [K  1.9  1010 M1s1
(66)] with O2
•, the latter yielding cytotoxic peroxynitrite, the
production of O2
• accompanying the synthesis of •NO requires
fine-tuning between the competition of SOD and •NO for
O2
•. A disturbance in the balance between the levels of •NO and
O2
• would determine differently the availability of •NO for
transcellular diffusion in hippocampal subregions, which, ac-
cordingly, would be reflected in effective •NO concentration.
The implications of this study for cell function are as follows: the
•NO production in the dependency of NMDA receptor activation
has been shown to participate in LTP as a retrogrademessenger but
also in excitotoxic cell death. In the former, •NO is assumed to be
at low nM concentration, whereas the latter is associated with
excessive stimulation ofNMDAreceptor and, therefore, it is alleged
a high production of possibly pathologic •NO concentration at the
micromolar level. A selective vulnerability of the CA1 subregion to
NMDAand glutamate stimuli has been reported (67). In this study,
subregions of hippocampus respond differently in terms of •NO
production. In the CA1 pyramidal cell layer, •NO concentration
reached the highest levels (typically 250 nM) but, even under
conditions of continuous NMDA stimulation, •NO rose only tran-
siently. Assuming that data obtained with isolated brain slices
reflect the concentrations in vivo, the claimed high concentration of
•NO at micromolar range in excitotoxicity achieved by excessive
stimulation of NMDA receptor may have to be reevaluated.
Moreover, it may have implications for the •NO-dependent exci-
totoxic pathways in the different regions after NMDA receptor
activation. Finally, the differential concentration dynamics may
reflect distinct regulatory pathways andbiological activities for •NO
in hippocampal subregions.
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